COVID-19 self-amplifying RNA vaccine (HDT Bio)

N/A

Report date: 2026/05/13 11:18:03

Base Information

Drug NameCOVID-19 self-amplifying RNA vaccine (HDT Bio)
Drug Alias NameRNA/LION™ COVID-19 VaccineRNA MCTI CIMATEC HDT Vaccine(HDT Bio)HGC-019HDT-301QTP-104
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > self-amplifying RNA vaccineVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsCoronavirus Disease 2019 (COVID-19)
Approved Indications in ChinaN/A
Original Approved Country/TerritoryIndia
Original Approved Date2022/06/29
Country/TerritoryUnited StatesSouth KoreaIndia
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesHDT Bio
China Registration ClassN/A

Develop Information

Active CompaniesAzidus BrasilQuratis IncSenai Cimatec +[4] 
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A